HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rachel Thijssen Selected Research

Rachel Thijssen Research Topics

Disease

8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2022 - 08/2015
5Neoplasms (Cancer)
11/2020 - 01/2019
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 01/2019
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 11/2020
2Disease Progression
01/2021 - 01/2019
1Leukemia
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Lymphoma (Lymphomas)
01/2020
1Lymphadenopathy
01/2016
1Lymphocytosis
01/2016

Drug/Important Bio-Agent (IBA)

11venetoclaxIBA
11/2022 - 08/2015
4Proteins (Proteins, Gene)FDA Link
11/2022 - 10/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2016
2Pharmaceutical PreparationsIBA
01/2021 - 01/2020
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2022
1navitoclaxIBA
01/2021
1ibrutinibIBA
01/2019
1Circulating Tumor DNAIBA
01/2019
11- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA
01/2016
1AntibodiesIBA
08/2015
1Phosphotransferases (Kinase)IBA
08/2015

Therapy/Procedure

5Therapeutics
11/2022 - 01/2019